Life sciences industries are seeing the end of the blockbuster drug business model. Today’s leaders are streamlining their operations, eliminating excess capacity, externalizing their non-core R&D teams, and are utilizing data mining to create a leaner organization. However, there is a need to more effectively manage this diverse, decentralized business model, and many organizations are struggling to find an effective means of doing so with their current disconnected software and data tools.
Download a copy of this new IDC whitepaper here to learn:
- Gain a clear understanding of the top issues facing biologics discovery researchers and product developers
- Learn of new capabilities being brought forth by advances in science and technology
- Hear the experts discuss Dassault Systemès’ new offering that addresses these issue and the potential barriers to adoption